These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 25777662)

  • 1. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments.
    Mega JL; Simon T
    Lancet; 2015 Jul; 386(9990):281-91. PubMed ID: 25777662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.
    Brown DG; Wilkerson EC; Love WE
    J Am Acad Dermatol; 2015 Mar; 72(3):524-34. PubMed ID: 25486915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).
    O'connor CT; Kiernan TJ; Yan BP
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):725-739. PubMed ID: 28571507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Managing antithrombotic therapy in vitreoretinal surgery].
    Gallice M; Rouberol F; Albaladejo P; Brillat Zaratzian E; Palombi K; Aptel F; Romanet JP; Chiquet C
    J Fr Ophtalmol; 2015 Jan; 38(1):61-73. PubMed ID: 25577431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
    Ganetsky VS; Hadley DE; Thomas TF
    Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Update on new antithrombotic treatments].
    Boehlen F; Tirefort-Dimitrova Y; de Moerloose P; Fontana P
    Rev Med Suisse; 2010 Jan; 6(232):109-12. PubMed ID: 20170027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Historical and future perspective of antithrombotic agents].
    Goto S
    Nihon Rinsho; 2014 Jul; 72(7):1193-7. PubMed ID: 25163307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants and antiplatelet agents. Clinical relevance and options for laboratory testing.
    Sibbing D; Spannagl M
    Hamostaseologie; 2014; 34(1):78-84. PubMed ID: 24301324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice.
    Golino P
    J Cardiovasc Med (Hagerstown); 2013 Dec; 14 Suppl 1():S22-30. PubMed ID: 24378838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
    Cairns JA; McMurtry MS
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period.
    Hall R; Mazer CD
    Anesth Analg; 2011 Feb; 112(2):292-318. PubMed ID: 21212258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Kaye AD; Manchikanti L; Novitch MB; Mungrue IN; Anwar M; Jones MR; Helander EM; Cornett EM; Eng MR; Grider JS; Harned ME; Benyamin RM; Swicegood JR; Simopoulos TT; Abdi S; Urman RD; Deer TR; Bakhit C; Sanapati M; Atluri S; Pasupuleti R; Soin A; Diwan S; Vallejo R; Candido KD; Knezevic NN; Beall D; Albers SL; Latchaw RE; Prabhakar H; Hirsch JA
    Pain Physician; 2019 Jan; 22(1S):S75-S128. PubMed ID: 30717501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.
    Cheng JW
    Clin Ther; 2012 Jun; 34(6):1209-20. PubMed ID: 22521881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.